This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

7 Stocks Hitting New Highs

Genomic Health

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Genomic Health (GHDX) is a molecular diagnostics company focused on the development and global commercialization of genomic-based clinical laboratory services, which analyzes the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions. This stock is trading up 1% at $28.84 in recent trading after hitting a 52-week of $28.90 earlier in the day.

Today's Range: $28.39-$28.90

52-week Range: $19.00-$28.90

Volume: 32,000 shares

Three-Month Average Volume: 174,591 shares

>>13 Biotech Stocks Bought and Sold by Hedge Funds

Genomic Health, one of TheStreet Ratings' top-rated biotech stocks, has a market cap of $849.04 million and an enterprise value of $764.87 million. The stock trades at a trailing price-to-earnings of 130.64 and a forward price-to-earnings of 70.10. Its estimated growth rate for this year is 92.9%, and for next year it's pegged at 51.9%.

From a technical standpoint, this stock is starting to flirt with a big breakout now that shares are pushing up towards some past overhead resistance at $28.78. Market players should watch for a sustained move and close above $28.78 on high-volume to trigger a bigger trend higher for Genomic Health. So far today, the volume is very light, so watch how the volume looks at the close. If we do get the breakout, then this stock will be trading in all-time high territory, which is bullish.
5 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
AAPL $93.70 -0.60%
FB $101.91 0.90%
GOOG $683.11 -0.15%
TSLA $150.47 4.73%
YHOO $26.76 -1.25%


Chart of I:DJI
DOW 15,660.18 -254.56 -1.60%
S&P 500 1,829.08 -22.78 -1.23%
NASDAQ 4,266.8370 -16.7550 -0.39%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs